Fidelity Advisor Biotechnology Fund MDGL Holdings History
Fidelity Advisor Biotechnology Fund's Madrigal Pharmaceuticals Inc Holding Summary
As of 2025-04-30, FIDELITY ADVISOR SERIES VII held - shares of Madrigal Pharmaceuticals Inc(MDGL), totaling N/A. This investment constitutes 0% of their stock portfolio, and FIDELITY ADVISOR SERIES VII now holds 0% of the outstanding Madrigal Pharmaceuticals Inc(MDGL) stock.
The initial trade took place in 2023Q1. And since then Fidelity Advisor Biotechnology Fund has made 3 purchases of MDGL, at an average price of $183.95, for a total of 99,700.00 shares. In addition, there have been 4 sales at an average price of $283.84 for 99,700.00 shares. Based on historical transaction data and MDGL's current price of $334.13, Fidelity Advisor Biotechnology Fund's estimated gain on his MDGL holdings is $9.96 Mil, reflecting a 54.30% gain to date.
Fidelity Advisor Biotechnology Fund MDGL ($334.13) Holding Chart
Fidelity Advisor Biotechnology Fund MDGL ($334.13) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
